Evolus Inc (EOLS)
Official siteHEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ
Market Cap: $438.83M
Last updated: Nov 17, 2026 at 4:26 PM ET
Evolus Inc (EOLS) Stock Chart
Evolus (EOLS) has a latest price of $6.69 on Nov 17, 2026, 28.1% below its 52-week high of $9.31. Its price fell 7.3% over the past 12 months. The month-end price fell 39.2% since Feb 2018, a compound annual decline of 5.6%.
Price Chart
From Feb 2018 to Oct 2026, its highest month-end close was $27.99 in Jun 2018 and its lowest $3.03 in Oct 2020, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart EOLS with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for EOLS.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 22.2%, and over 6 months it rose 4.0%. The month-end price fell 3.3% over the 3 years through Oct 2026, a compound annual decline of 1.1%.
| Period | Change |
|---|---|
| 1 month | -9.1% |
| 3 months | -22.2% |
| 6 months | +4.0% |
| 12 months | -7.3% |
| 12 months, with dividends | -7.3% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -3.3% | -1.1% |
| 5 years | -6.0% | -1.2% |
| Since Feb 2018 | -39.2% | -5.6% |
Price by Year
Its best calendar year was 2021, when the price rose 93.8%, and its weakest was 2020, when it fell 72.4%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $7.35 | +10.5% |
| 2025 | $6.65 | -39.8% |
| 2024 | $11.04 | +4.8% |
| 2023 | $10.53 | +40.2% |
| 2022 | $7.51 | +15.4% |
| 2021 | $6.51 | +93.8% |
| 2020 | $3.36 | -72.4% |
| 2019 | $12.17 | +2.3% |
Trading Range
The price is 11.0% below its 50-day average of $7.52 and 4.7% above its 200-day average of $6.39.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $6.69 | |
| 52-week high | $9.31 | -28.1% |
| 52-week low | $3.86 | +73.3% |
| 50-day average | $7.52 | -11.0% |
| 200-day average | $6.39 | +4.7% |
Price Risk
Over 3 years, its largest fall from a peak was 77.5%.
| Measure | Value |
|---|---|
| 1-year beta | 1.34 |
| Largest fall, 1 year | -45.4% |
| Largest fall, 3 years | -77.5% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About EOLS
What is EOLS's 1-year price change?
Evolus's price fell 7.3% over the past 12 months. With dividends included, the 12-month total return was -7.3%.
What is EOLS's 5-year price change?
Evolus's month-end price fell 6.0% over the 5 years through Oct 2026, a compound annual decline of 1.2%. These figures leave out dividends.
What is EOLS's 52-week high and low?
Evolus's 52-week high is $9.31 and its 52-week low is $3.86. Its latest price of $6.69 on Nov 17, 2026 is 28.1% below the high.
What is EOLS's beta?
Evolus's 1-year beta against the S&P 500 is 1.34, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 45.4%.
Is the EOLS chart free?
Yes. Advanced Charting for EOLS is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
EOLS pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors